2026 NPPES data Addiction Medicine (Internal Medicine) Physician NPI 1154315059 M.D.
Verify on CMS →

LINDA THOMAS-HEMAK, M.D.

Addiction Medicine (Internal Medicine) Physician in JERMYN, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 327 beneficiaries · Addiction Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$237.86
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LINDA THOMAS-HEMAK, M.D. filed 5,116 Medicare Part D claims in 2023 as a Addiction Medicine (Internal Medicine) Physician in JERMYN, Pennsylvania, prescribing 81% generic.

5K
Part D claims, 2023
81%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LINDA THOMAS-HEMAK, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

5,116 Top 6% higher than 94% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

LINDA THOMAS-HEMAK, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LINDA THOMAS-HEMAK, M.D.?

Quality data not reported

NPI registry status

Active

Issued 09/07/2005

NPI 1154315059

Primary specialty

Addiction Medicine (Internal Medicine) Physician

Niche

553 US NPIs in this specialty

Medicare Part D claims

5,116 265% vs specialty avg

2023 prescription claims

Specialty avg: 1,403

Specialty distribution in Pennsylvania

How Addiction Medicine (Internal Medicine) Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Addiction Medicine (Internal Medicine) Physician share within Pennsylvania

1. Addiction Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Internal Medicine) Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LINDA THOMAS-HEMAK, M.D. is a Addiction Medicine (Internal Medicine) Physician provider practicing in JERMYN, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1154315059. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LINDA THOMAS-HEMAK, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Internal Medicine) Physician provider holding M.D. credentials at 5 S WASHINGTON AVE, JERMYN, PA, 18433, with a listed phone of (570) 383-9934. NPI 1154315059 was issued on 09/07/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what THOMAS-HEMAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,116 prescription claims written by this provider, covering 327 Medicare beneficiaries and totaling roughly $621K in drug spend, split 19% brand-name and 81% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 553 enrolled providers across 46 states and an average of 1,403 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5 S WASHINGTON AVE
JERMYN, PA 18433

Provider Details

NPI 1154315059
Specialty Addiction Medicine (Internal Medicine) Physician
Credentials M.D.
Gender Female
NPI Issued 09/07/2005

Hospital and facility affiliations

Facilities where LINDA THOMAS-HEMAK, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE WRIGHT CENTER MEDICAL GROUP
JERMYN, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LINDA THOMAS-HEMAK, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$238

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to LINDA THOMAS-HEMAK, M.D.. To verify LINDA THOMAS-HEMAK, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

LINDA THOMAS-HEMAK, M.D. — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 5,116 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,116
Total Claims
$621K
Total Drug Cost
327
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,898
Total Day Supply
257,703
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$525K
Generic Drug Cost
$89K
Antibiotic Claims
47

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.17
Gender Split
67% female / 33% male
Age Distribution
<65: 39, 65-74: 133, 75-84: 112, 85+: 43

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
291
Metformin Hcl Er
Metformin Hcl
241
Levothyroxine Sodium
205
Losartan Potassium
173
Carvedilol
160
Amlodipine Besylate
154
Omeprazole
146
Eliquis
Apixaban
138
Pantoprazole Sodium
136
Ozempic
Semaglutide
132

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Internal Medicine) Physician Overview

How LINDA THOMAS-HEMAK, M.D. fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.

553
Addiction Medicine (Internal Medicine) Physician Providers in US
46
States with Addiction Medicine (Internal Medicine) Physician
1,403
Avg Claims per Provider

LINDA THOMAS-HEMAK, M.D.'s 5,116 claims are above the specialty average of 1,403.

Nearby Addiction Medicine (Internal Medicine) Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as THOMAS-HEMAK.

Compare Addiction Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LINDA THOMAS-HEMAK, M.D.'s specialty?
LINDA THOMAS-HEMAK, M.D. specializes in Addiction Medicine (Internal Medicine) Physician and practices in JERMYN, Pennsylvania. Credentials: M.D..
How much does LINDA THOMAS-HEMAK, M.D. prescribe under Medicare Part D?
In 2023, LINDA THOMAS-HEMAK, M.D. wrote 5,116 Medicare Part D claims totaling $621K in drug costs for 327 beneficiaries.
Where is LINDA THOMAS-HEMAK, M.D. located?
LINDA THOMAS-HEMAK, M.D. is located at 5 S WASHINGTON AVE, JERMYN, PA, 18433. Phone: (570) 383-9934.
What is LINDA THOMAS-HEMAK, M.D.'s NPI number?
LINDA THOMAS-HEMAK, M.D.'s National Provider Identifier (NPI) is 1154315059, issued on 09/07/2005.
Does LINDA THOMAS-HEMAK, M.D. prescribe more brand-name or generic drugs?
LINDA THOMAS-HEMAK, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $525K in brand drug costs.
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US?
There are 553 Addiction Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Addiction Medicine (Internal Medicine) Physician provider writes 1,403 Medicare Part D claims per year.
What drugs does LINDA THOMAS-HEMAK, M.D. prescribe most often?
Based on 2023 Medicare Part D data, LINDA THOMAS-HEMAK, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Metformin Hcl Er, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LINDA THOMAS-HEMAK, M.D. accept Medicare?
LINDA THOMAS-HEMAK, M.D. appears in CMS Medicare data with 5,116 Part D claims and 327 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LINDA THOMAS-HEMAK, M.D.'s credentials?
LINDA THOMAS-HEMAK, M.D.'s NPI is 1154315059 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology